NO20075206L - Medisinske sammensetninger av salter, chelatorer og/eller frie syrer av alfa hydroksyl organiske syrer samt relaterte prosesser og fremgangsmater - Google Patents
Medisinske sammensetninger av salter, chelatorer og/eller frie syrer av alfa hydroksyl organiske syrer samt relaterte prosesser og fremgangsmaterInfo
- Publication number
- NO20075206L NO20075206L NO20075206A NO20075206A NO20075206L NO 20075206 L NO20075206 L NO 20075206L NO 20075206 A NO20075206 A NO 20075206A NO 20075206 A NO20075206 A NO 20075206A NO 20075206 L NO20075206 L NO 20075206L
- Authority
- NO
- Norway
- Prior art keywords
- processes
- alpha
- organic acids
- hydroxy organic
- acids
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66244605P | 2005-03-16 | 2005-03-16 | |
PCT/US2006/009394 WO2006101922A2 (fr) | 2005-03-16 | 2006-03-16 | Compositions medicinales de sels, chelates et/ou acides libres d'acides organiques alpha hydroxyle et processus et procedes associes |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20075206L true NO20075206L (no) | 2007-12-17 |
Family
ID=37024369
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20075206A NO20075206L (no) | 2005-03-16 | 2007-10-11 | Medisinske sammensetninger av salter, chelatorer og/eller frie syrer av alfa hydroksyl organiske syrer samt relaterte prosesser og fremgangsmater |
Country Status (10)
Country | Link |
---|---|
US (1) | US20090275656A1 (fr) |
EP (1) | EP1858500A4 (fr) |
JP (1) | JP2008533163A (fr) |
AU (1) | AU2006227661A1 (fr) |
CA (1) | CA2609615A1 (fr) |
MX (1) | MX2007011200A (fr) |
NO (1) | NO20075206L (fr) |
RU (1) | RU2007138220A (fr) |
WO (1) | WO2006101922A2 (fr) |
ZA (1) | ZA200707757B (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008008837A2 (fr) * | 2006-07-11 | 2008-01-17 | Lynpete Trading 6 (Pty) Ltd. Trading As Genetic Health Enterprises | Méthodes pour accroître les niveaux de tryptophane et de nicotinamide in vivo |
DE102007052223A1 (de) * | 2007-10-31 | 2009-05-14 | Bionorica Ag | Hydrolysate aus Pflanzenextrakten sowie diese enthaltendes antibakterielles Mittel |
JP5334508B2 (ja) * | 2008-09-10 | 2013-11-06 | Towa Corporation 株式会社 | 高活性poaの製法 |
SI2744504T1 (sl) | 2011-08-19 | 2015-09-30 | Bionorica Se | Postopek za pripravo suhih ekstraktov |
HUE052328T2 (hu) | 2012-06-11 | 2021-04-28 | Callaghan Innovation | Feijoa gyümölcs kivonat |
US10098922B1 (en) * | 2017-11-30 | 2018-10-16 | Optigenex, Inc. | Increasing telomere length in a cell |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6028111A (en) * | 1996-03-08 | 2000-02-22 | Oxigene, Inc. | Compositions and use of benzamides and nicotinamides as anti-inflammatory agents |
US6238675B1 (en) * | 1997-02-27 | 2001-05-29 | Campamed Corp. | Method of preparation and composition of a water soluble extract of the plant species Uncaria for enhancing immune, anti-inflammatory and anti-tumor processes of warm blooded animals |
US6361805B2 (en) * | 1997-02-27 | 2002-03-26 | Ronald W. Pero | Method of preparation and composition of a water soluble extract of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals |
US6039949A (en) * | 1997-02-27 | 2000-03-21 | Campamed, Inc. | Method of preparation and composition of a water soluble extract of the plant species uncaria |
JPH11140014A (ja) * | 1997-11-10 | 1999-05-25 | Mitsui Chem Inc | キナ酸の精製方法 |
EP1339729A2 (fr) * | 2000-11-28 | 2003-09-03 | The Regents Of The University Of California | Composes anti-inflammatoires derives de pseudopterogorgia elisabethae |
US6964784B2 (en) * | 2002-03-07 | 2005-11-15 | Optigenex, Inc. | Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals |
US20040214215A1 (en) * | 2003-03-07 | 2004-10-28 | Yu Ruey J. | Bioavailability and improved delivery of alkaline pharmaceutical drugs |
-
2006
- 2006-03-16 EP EP06738456A patent/EP1858500A4/fr not_active Withdrawn
- 2006-03-16 CA CA002609615A patent/CA2609615A1/fr not_active Abandoned
- 2006-03-16 JP JP2008502014A patent/JP2008533163A/ja active Pending
- 2006-03-16 US US11/886,345 patent/US20090275656A1/en not_active Abandoned
- 2006-03-16 RU RU2007138220/15A patent/RU2007138220A/ru not_active Application Discontinuation
- 2006-03-16 MX MX2007011200A patent/MX2007011200A/es not_active Application Discontinuation
- 2006-03-16 AU AU2006227661A patent/AU2006227661A1/en not_active Abandoned
- 2006-03-16 WO PCT/US2006/009394 patent/WO2006101922A2/fr active Application Filing
-
2007
- 2007-09-11 ZA ZA2007/07757A patent/ZA200707757B/en unknown
- 2007-10-11 NO NO20075206A patent/NO20075206L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20090275656A1 (en) | 2009-11-05 |
WO2006101922A2 (fr) | 2006-09-28 |
RU2007138220A (ru) | 2009-04-27 |
WO2006101922A3 (fr) | 2007-09-13 |
CA2609615A1 (fr) | 2006-09-28 |
AU2006227661A1 (en) | 2006-09-28 |
EP1858500A2 (fr) | 2007-11-28 |
ZA200707757B (en) | 2012-02-29 |
EP1858500A4 (fr) | 2013-01-16 |
JP2008533163A (ja) | 2008-08-21 |
MX2007011200A (es) | 2008-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20075206L (no) | Medisinske sammensetninger av salter, chelatorer og/eller frie syrer av alfa hydroksyl organiske syrer samt relaterte prosesser og fremgangsmater | |
BR112013020620A2 (pt) | análogos de ácido 4-hidroxibutírico | |
AR075423A1 (es) | Composicion farmaceutica que comprende un inhibidor de sglt-2, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y sus usos | |
NO20091605L (no) | Pyridinonforbindelser | |
BRPI0514448A (pt) | derivados do ácido bifenil-oxiacético para uso no tratamento de doenças respiratórias | |
BR112013021236A2 (pt) | composto, composição,e, método de tratamento de um distúrbio, uma condição ou uma doença | |
BRPI0609393B8 (pt) | usos de um composto 11-desóxi-prostaglandina | |
WO2008040548A3 (fr) | Traitement pour l'hépatite stéatosique non alcoolique | |
NO20085068L (no) | Fenylamino-benzoksazolsubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter | |
BR112012017073A2 (pt) | Método de tratamento de condições neurológicas com glicosídeos cardíacos | |
CO6410306A2 (es) | Inhibidor de sglt2 para tratar diabetes mellitus de tipo 1, diabetes mellitus de tipo 2, alteración de la tolerancia a la glucosa e hiperglucemia | |
MX2007005679A (es) | Metodo para tratamiento de desordenes de movimiento. | |
EA201300550A1 (ru) | Фармацевтическая композиция, способы лечения и их применение | |
BR112015001618A2 (pt) | composições fungicidas | |
BRPI0516454A (pt) | compostos, processo para a preparação de um composto, composição farmacêutica que o compreende, sua utilização, método para o tratamento e profilaxia de enfermidades, e de diabetes do tipo ii | |
HK1114876A1 (en) | Arthrospira-based compositions and uses thereof | |
EA201070477A1 (ru) | Транс-кломифен для лечения метаболического синдрома | |
BRPI0517846A (pt) | azaindolcarboxamidas | |
MX2009005413A (es) | Formas cristalinas del acido zoledronico. | |
MX2007004955A (es) | Metodo de tratar cancer con formulaciones de compeusto de platino a base de lipido administradas intraperitonealmente. | |
MX337396B (es) | Metodo para el tratamiento de enfermedades del riñon poliquisticas con derivados de ceramica. | |
BRPI0510370A (pt) | derivados de ácido fenoxi-alquil-carboxìlico no tratamento de doenças inflamatórias | |
BRPI0607156A2 (pt) | composto, composição farmacêutica, uso do composto, kit farmacêutico, método para estimular a absorção de glicose por células de músculo e/ou célula de adipócito e método para estimular a secreção pancreática | |
BR112013028598A2 (pt) | método para promover o crescimento de plantas | |
CY1109743T1 (el) | Παραγωγα των 2-βενζοϋλο-ιμιδαζοπυριδινων, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application | ||
RE | Reestablishment of rights (par. 72 patents act) | ||
FC2A | Withdrawal, rejection or dismissal of laid open patent application |